Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary

Adaptive Biotechnologies

16/02/2022 24:04

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 43 cents​​ per share for the quarter ended in
December. The mean expectation of seven analysts for the quarter
was for a loss of 45 cents per share.
    * Revenue rose 25.7% to $37.93 million from a year ago; 
analysts
expected $36.70 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 43 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Adaptive Biotechnologies Corp shares had fallen by 47.7%
this
quarter.
    * The company reported a quarterly loss of $61.43 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $40.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 16 at 12:04 a.m.
 ​All figures in US dollars unless otherwise stated